1. Home
  2. TEVA vs ZBH Comparison

TEVA vs ZBH Comparison

Compare TEVA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • ZBH
  • Stock Information
  • Founded
  • TEVA 1901
  • ZBH 1927
  • Country
  • TEVA Israel
  • ZBH United States
  • Employees
  • TEVA N/A
  • ZBH N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • ZBH Industrial Specialties
  • Sector
  • TEVA Health Care
  • ZBH Health Care
  • Exchange
  • TEVA Nasdaq
  • ZBH Nasdaq
  • Market Cap
  • TEVA 20.1B
  • ZBH N/A
  • IPO Year
  • TEVA N/A
  • ZBH N/A
  • Fundamental
  • Price
  • TEVA $16.41
  • ZBH $93.76
  • Analyst Decision
  • TEVA Strong Buy
  • ZBH Hold
  • Analyst Count
  • TEVA 7
  • ZBH 21
  • Target Price
  • TEVA $24.71
  • ZBH $112.74
  • AVG Volume (30 Days)
  • TEVA 10.0M
  • ZBH 2.1M
  • Earning Date
  • TEVA 07-30-2025
  • ZBH 08-07-2025
  • Dividend Yield
  • TEVA N/A
  • ZBH 1.01%
  • EPS Growth
  • TEVA N/A
  • ZBH N/A
  • EPS
  • TEVA N/A
  • ZBH 4.51
  • Revenue
  • TEVA $16,616,000,000.00
  • ZBH $7,698,500,000.00
  • Revenue This Year
  • TEVA $5.69
  • ZBH $7.65
  • Revenue Next Year
  • TEVA N/A
  • ZBH $5.63
  • P/E Ratio
  • TEVA N/A
  • ZBH $21.11
  • Revenue Growth
  • TEVA 3.82
  • ZBH 3.30
  • 52 Week Low
  • TEVA $12.47
  • ZBH $89.22
  • 52 Week High
  • TEVA $22.80
  • ZBH $116.71
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 41.31
  • ZBH 51.48
  • Support Level
  • TEVA $16.55
  • ZBH $92.13
  • Resistance Level
  • TEVA $17.07
  • ZBH $96.92
  • Average True Range (ATR)
  • TEVA 0.37
  • ZBH 1.92
  • MACD
  • TEVA -0.08
  • ZBH 0.43
  • Stochastic Oscillator
  • TEVA 9.29
  • ZBH 55.30

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: